Guardant Health (GH) Liabilities and Shareholders Equity (2017 - 2026)
Guardant Health's Liabilities and Shareholders Equity history spans 9 years, with the latest figure at $2.0 billion for Q4 2025.
- On a quarterly basis, Liabilities and Shareholders Equity rose 35.54% to $2.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $6.0 billion, a 5.86% decrease, with the full-year FY2025 number at $2.0 billion, up 35.54% from a year prior.
- Liabilities and Shareholders Equity hit $2.0 billion in Q4 2025 for Guardant Health, up from $1.3 billion in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for GH hit a ceiling of $2.3 billion in Q1 2021 and a floor of $1.3 billion in Q3 2025.
- Historically, Liabilities and Shareholders Equity has averaged $1.8 billion across 5 years, with a median of $1.7 billion in 2023.
- Biggest five-year swings in Liabilities and Shareholders Equity: soared 147.5% in 2021 and later decreased 29.02% in 2023.
- Tracing GH's Liabilities and Shareholders Equity over 5 years: stood at $2.2 billion in 2021, then dropped by 26.97% to $1.6 billion in 2022, then grew by 10.96% to $1.8 billion in 2023, then decreased by 16.84% to $1.5 billion in 2024, then surged by 35.54% to $2.0 billion in 2025.
- Business Quant data shows Liabilities and Shareholders Equity for GH at $2.0 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.3 billion in Q2 2025.